168 related articles for article (PubMed ID: 34144386)
1. Utility of the "2019 ACR/EULAR classification criteria" for the management of patients with IgG4-related disease.
Della-Torre E; Lanzillotta M; Germanò T; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L
Semin Arthritis Rheum; 2021 Aug; 51(4):761-765. PubMed ID: 34144386
[TBL] [Abstract][Full Text] [Related]
2. Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes.
Lanzillotta M; Campochiaro C; Mancuso G; Ramirez GA; Capurso G; Falconi M; Dagna L; Della-Torre E
Rheumatology (Oxford); 2020 Sep; 59(9):2435-2442. PubMed ID: 32591828
[TBL] [Abstract][Full Text] [Related]
3. The external validation of the 2019 ACR/EULAR classification criteria for IgG4-related disease in a large cohort from China.
Liu Z; Nie Y; Peng Y; Lu H; Zhang P; Li J; Sun R; Li J; Sun B; He X; Zhou J; Fei Y; Peng L; Zhang W; Zeng X
Semin Arthritis Rheum; 2023 Aug; 61():152202. PubMed ID: 37167774
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics and Classification Criteria Performance in a Single-Center Cohort of 114 Patients With Immunoglobulin G4-Related Disease.
Spandorfer R; Ahmad M; Khosroshahi A
J Clin Rheumatol; 2023 Jan; 29(1):23-28. PubMed ID: 35905474
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of
Bai Z; Zhou T; Yu Z; Chen Y; Dong L
Ann Nucl Med; 2022 Jul; 36(7):651-660. PubMed ID: 35604531
[TBL] [Abstract][Full Text] [Related]
6. Radiology domain in the diagnosis of IgG4-RD according to the 2019 American College of Rheumatology and European League Against Rheumatism classification.
Elbanna KY; Kowa JY; Mirajkar N; Khalili K; Kim TK
Insights Imaging; 2024 Mar; 15(1):94. PubMed ID: 38530483
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort.
Vikse J; Midtvedt Ø; Fevang BS; Garen T; Palm Ø; Wallenius M; Bakland G; Norheim KB; Molberg Ø; Hoffmann-Vold AM
Arthritis Res Ther; 2023 Sep; 25(1):163. PubMed ID: 37670401
[TBL] [Abstract][Full Text] [Related]
8. [IgG4-related disease: Diagnostic criteria evolution toward the 2019 ACR/EULAR classification criteria].
Schleinitz N; Briantais A; Ebbo M
Rev Med Interne; 2020 Dec; 41(12):814-821. PubMed ID: 32732082
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients.
An W; Wu Z; Li M; Yu H; Zhao X; Wang X; Wang Y; Wang Q; Duan W; Kong Y; Ma H; Ou X; You H; Liu Y; Li P; Duan T; Jia J
Orphanet J Rare Dis; 2022 Aug; 17(1):307. PubMed ID: 35927746
[TBL] [Abstract][Full Text] [Related]
10. Positive disease-specific autoantibodies have limited clinical significance in diagnosing IgG4-related disease in daily clinical practice.
Mizushima I; Yamano T; Kawahara H; Hibino S; Nishioka R; Zoshima T; Hara S; Ito K; Fujii H; Nomura H; Kawano M
Rheumatology (Oxford); 2021 Jul; 60(7):3317-3325. PubMed ID: 33313857
[TBL] [Abstract][Full Text] [Related]
11. Performance of classification and diagnostic criteria for IgG4-related disease and comparison of patients with and without IgG4-related disease.
Kogami M; Abe Y; Ando T; Makiyama A; Yamaji K; Tamura N
Sci Rep; 2023 Feb; 13(1):2509. PubMed ID: 36782006
[TBL] [Abstract][Full Text] [Related]
12. Performance of the 2019 ACR/EULAR Classification Criteria for IgG4-Related Disease in a Large Chinese Cohort.
An ZY; Fu JN; Zeng QZ; Zhufeng YZ; Ning XR; Li HJ; Ma XB; Wang KK; Bian WJ; Zhang YX; Li ZG; Liu YY
J Clin Rheumatol; 2024 Mar; 30(2):73-78. PubMed ID: 38268091
[TBL] [Abstract][Full Text] [Related]
13. IgG4-related uveitis. A French cohort and literature review.
Stuchfield-Denby E; De Sainte Marie B; Hie M; Hatchuel Y; Gerber A; Bencheikh S; Pugnet G; Groh M; Farhat MM; Urbina D; Ebbo M; Schleinitz N
Semin Arthritis Rheum; 2024 Feb; 64():152278. PubMed ID: 38000318
[TBL] [Abstract][Full Text] [Related]
14. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS; Naden RP; Chari S; Choi H; Della-Torre E; Dicaire JF; Hart PA; Inoue D; Kawano M; Khosroshahi A; Kubota K; Lanzillotta M; Okazaki K; Perugino CA; Sharma A; Saeki T; Sekiguchi H; Schleinitz N; Stone JR; Takahashi N; Umehara H; Webster G; Zen Y; Stone JH;
Arthritis Rheumatol; 2020 Jan; 72(1):7-19. PubMed ID: 31793250
[TBL] [Abstract][Full Text] [Related]
15. Serum IgG4-negative IgG4-related disease with a cardiac mass: A case report.
Namba K; Sakai D; Mikamo H; Sugizaki Y; Sugiura Y; Hiruta N; Matsuzawa Y; Kaneko K
Medicine (Baltimore); 2023 Aug; 102(31):e34533. PubMed ID: 37543826
[TBL] [Abstract][Full Text] [Related]
16. IgG4-related disease administered dupilumab: case series and review of the literature.
Kanda M; Kamekura R; Sugawara M; Nagahata K; Suzuki C; Takano K; Takahashi H
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36894196
[TBL] [Abstract][Full Text] [Related]
17. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS; Naden RP; Chari S; Choi HK; Della-Torre E; Dicaire JF; Hart PA; Inoue D; Kawano M; Khosroshahi A; Lanzillotta M; Okazaki K; Perugino CA; Sharma A; Saeki T; Schleinitz N; Takahashi N; Umehara H; Zen Y; Stone JH;
Ann Rheum Dis; 2020 Jan; 79(1):77-87. PubMed ID: 31796497
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry in IgG4-related disease diagnosis.
Onwuka DC; Chen LYC; Zhan SH; Seidman MA; Cartagena L; Killow V; Abou-Tak H; Mattman A; Carruthers MN
Sci Rep; 2024 Jan; 14(1):2584. PubMed ID: 38297074
[TBL] [Abstract][Full Text] [Related]
19. IgG4-related disease with multiorgan involvement: a case-based review.
Tarte NN; Ravipati CS; Leon de la Rocha JA; Rinker E; Patel NJ
Rheumatol Int; 2021 Jun; 41(6):1169-1174. PubMed ID: 33880637
[TBL] [Abstract][Full Text] [Related]
20. [IgG4-related diseases of retroperitoneum in urinary and male reproductive system: a clinicopathological analysis of eleven cases].
Su WJ; Chang N; He HY
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):970-975. PubMed ID: 36207908
[No Abstract] [Full Text] [Related]
[Next] [New Search]